CS
Chandana Shrivastava
About Chandana Shrivastava
Data last updated:
Chandana Shrivastava is a Director at Global Drugs And Vaccines Private Limited (since 2022) and Director at Nucleus Laboratories (India) Limted (since 2022). The companies operate in Pharma. The 2 current companies with reported revenue have a combined latest revenue of ₹7.34 Cr; the largest is Global Drugs And Vaccines Private Limited at ₹4.86 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Global Drugs And Vaccines Private Limited U51909UP2022PTC162092 | Director | 08 Apr 2022 | 2022 | ₹4.86 Cr (FY 2025) | Active |
 Nucleus Laboratories (India) Limted U24231UP1999PLC024944 | Director | 07 Mar 2022 | 1999 | ₹2.48 Cr (FY 2020) | Active |
Board colleagues of Chandana Shrivastava
| Name | DIN | Company | Designation |
|---|---|---|---|
| Gyan Prakash Shrivastava | 08545629 | Global Drugs And Vaccines Private Limited , Nucleus Laboratories (India) Limted | Director |
| Madhulika Srivastava | 09566044 | Global Drugs And Vaccines Private Limited | Director |
| Ashish Kumar Singh | 01189756 | Nucleus Laboratories (India) Limted | Director |
| Debashish Saha | 10160104 | Nucleus Laboratories (India) Limted | Director |
| Himani Shukla | 11219612 | Nucleus Laboratories (India) Limted | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Chandana Shrivastava
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Chandana Shrivastava
Chandana Shrivastava currently holds 2 directorships: Global Drugs And Vaccines Private Limited (Director, since 08 Apr 2022, revenue ₹4.86 Cr (FY 2025)); Nucleus Laboratories (India) Limted (Director, since 07 Mar 2022, revenue ₹2.48 Cr (FY 2020)).
Chandana Shrivastava was first appointed on 07 Mar 2022 as Director at Nucleus Laboratories (India) Limted.
The 2 current companies of Chandana Shrivastava that report revenue have a combined latest revenue of ₹7.34 Cr: Global Drugs And Vaccines Private Limited ₹4.86 Cr (FY 2025); Nucleus Laboratories (India) Limted ₹2.48 Cr (FY 2020).
The current boards of Chandana Shrivastava's companies include Gyan Prakash Shrivastava (Global Drugs And Vaccines Private Limited), Madhulika Srivastava (Global Drugs And Vaccines Private Limited), Ashish Kumar Singh (Nucleus Laboratories (India) Limted), Debashish Saha (Nucleus Laboratories (India) Limted), Himani Shukla (Nucleus Laboratories (India) Limted).